Major lupus organ involvement: severe lupus nephritis (Q37800295)

23 August 2017

Major lupus organ involvement: severe lupus nephritis (English)

1 reference

23 August 2017

Y Avihingsanon

1

1 reference

PubMed ID

20947547

23 August 2017

N Hirankarn

series ordinal

2

1 reference

23 August 2017

1 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

19

1 reference

23 August 2017

12

1 reference

23 August 2017

1391-1398

1 reference

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

23 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Lupus nephritis: clinicopathological study of 162 cases in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Newer drugs for the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Lupus in the developing world--is it any different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Demographic differences in the development of lupus nephritis: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Relevance of anti-C1q autoantibodies to lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

T cells and B cells in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Recent insights into the genetic basis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Epigenetic regulation and the pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Genetics of human lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Silent nephritis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Mycophenolate mofetil and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Successful treatment of class V+IV lupus nephritis with multitarget therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Sequential therapies for proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

Pharmacokinetics of mycophenolic acid in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310376522

21 January 2018

Identifiers

DOI

10.1177/0961203310376522

1 reference

23 August 2017

1 reference

PubMed ID

20947547